The Role of BEHAB/Brevican in the Tumor Microenvironment: Mediating Glioma Cell Invasion and Motility

Adv Exp Med Biol. 2020:1272:117-132. doi: 10.1007/978-3-030-48457-6_7.

Abstract

Malignant gliomas are the most common tumors in the central nervous system (CNS) and, unfortunately, are also the most deadly. The lethal nature of malignant gliomas is due in large part to their unique and distinctive ability to invade the surrounding neural tissue. The invasive and dispersive nature of these tumors makes them particularly challenging to treat, and currently there are no effective therapies for malignant gliomas. The brain tumor microenvironment plays a particularly important role in mediating the invasiveness of gliomas, and, therefore, understanding its function is key to developing novel therapies to treat these deadly tumors. A defining aspect of the tumor microenvironment of gliomas is the unique composition of the extracellular matrix that enables tumors to overcome the typically inhibitory environment found in the CNS. One conspicuous component of the glioma tumor microenvironment is the neural-specific ECM molecule, brain-enriched hyaluronan binding (BEHAB)/brevican (B/b). B/b is highly overexpressed in gliomas, and its expression in these tumors contributes importantly to the tumor invasiveness and aggressiveness. However, B/b is a complicated protein with multiple splice variants, cleavage products, and glycoforms that contribute to its complex functions in these tumors and provide unique targets for tumor therapy. Here we review the role of B/b in glioma tumor microenvironment and explore targeting of this protein for glioma therapy.

Keywords: ADAMTS4; BEHAB; Chondroitin sulfate; ECM; EGF receptor; Fibronectin; Glioma dispersion; Glioma-initiating cells; Glycoform; Glycosylation; Hyaluronan; Lectican; MMP; Proteoglycan; TME.

Publication types

  • Review

MeSH terms

  • Brain Neoplasms / pathology*
  • Brevican / metabolism*
  • Cell Movement*
  • Glioma / pathology*
  • Humans
  • Neoplasm Invasiveness
  • Tumor Microenvironment*

Substances

  • Brevican